Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 30, 2026
Why Is Coastal Financial Corporation (CCB) Stock Down -44.16% Today?

Why Is Coastal Financial Corporation (CCB) Stock Down -44.16% Today?

Key Takeaways

  • CCB shares plunged approximately 44.16% in Thursday's regular session, trading near $39.46 after closing the prior session at $70.66.
  • The primary catalyst: A disastrous Q2 2026 earnings report revealing a net loss of $42.1 million, or -$2.76 per share, driven by $68.8 million in pre-tax charges tied to a single troubled Banking-as-a-Service (BaaS) partner.
  • Secondary pressure came from the recently announced CFO departure — Brandon Soto is stepping down in August — and the appointment of a new Executive Chairman.
  • Revenue beat expectations at $178.1 million (vs. $148.5 million consensus), but the magnitude of credit-related writedowns obliterated any positive sentiment.
  • Broader context: The stock had already fallen roughly 38% year-to-date before today's collapse, and this decline has now pushed shares far below the prior 52-week low of $66.50.
  • What traders are watching next: Management's conference call commentary on the timeline for resolving the troubled partner relationship, and whether the issue truly remains isolated to a single partner.

Opening Summary

Shares of CCB, the Everett, Washington-based bank holding company for Coastal Community Bank — which operates a traditional community banking segment alongside an industry-leading Banking-as-a-Service (BaaS) platform known as CCBX — cratered in Thursday's trading session, plummeting roughly 44.16% to approximately $39.46 from a previous close of $70.66. The selloff was triggered by the company's second-quarter 2026 earnings release, which revealed a staggering net loss driven by outsized credit charges concentrated in a single partner relationship, completely overshadowing what was otherwise a quarter of strong revenue growth and record net interest income.

Q2 Earnings: A Quarter Marred by a Single Partner Blow-Up

Coastal Financial reported Q2 2026 results pre-market on Thursday that can only be described as a tale of two narratives. On one hand, total revenue surged to $178.1 million, handily beating analyst estimates of $148.5 million and growing 49.1% year-over-year. Net interest income set a record at $89.4 million, and net interest margin expanded to 7.27% from 7.00% in the prior quarter. The core CCBX portfolio — excluding the troubled partner — grew loans by 46% year-over-year and showed improving credit quality metrics.

On the other hand, the bottom line told a dramatically different story. The company swung to a net loss of $42.1 million, or -$2.76 per diluted share — a catastrophic miss versus the consensus estimate of $1.01 per share in profit. The culprit: $68.8 million in pre-tax charges stemming from a single, isolated CCBX partner relationship. These charges broke down into a $22.8 million provision for credit losses related to amounts not expected to be recovered under the partner's indemnification arrangement, and a $46.0 million valuation adjustment to the credit enhancement asset associated with that same partner. An additional $4.4 million in accelerated software amortization from technology modernization efforts further pressured the bottom line.

Leadership Transition Adds to Uncertainty

Compounding investor anxiety, CCB recently disclosed that Executive Vice President and Chief Financial Officer Brandon Soto will step down effective August 15, 2026, to become CEO of a banking subsidiary for a privately held fintech company. While the company characterized Soto's departure as amicable and unrelated to any disagreements, the exit of a key financial executive on the heels of a quarter defined by partner-related credit losses has amplified concerns about oversight and risk management within the BaaS platform. Joel Edwards, a former CFO, has been appointed as Interim CFO. Separately, the company announced the appointment of Christopher D. Adams as Executive Chairman, expanding his role to focus on long-term strategy and leadership development.

Market Context and Trading Activity

The severity of Thursday's decline stands out even against a backdrop of prolonged weakness for CCB shares, which had already fallen approximately 38% year-to-date and roughly 26% over the trailing twelve months prior to this earnings-driven rout. Today's plunge pushed the stock well below its prior 52-week low of $66.50, effectively resetting the stock's entire multi-year valuation framework. Trading volume was dramatically elevated, with shares exchanging hands at multiples of the average daily volume, reflecting broad-based institutional repositioning. The move diverged sharply from the broader regional banking sector and the Nasdaq Composite, confirming that the selloff was overwhelmingly stock-specific rather than macro-driven. The stock opened significantly lower and continued to slide through the session, indicating persistent selling pressure and limited dip-buying interest.

What Comes Next for CCB

The path forward for CCB hinges heavily on management's ability to convince the market that the troubled partner situation is truly contained. CEO Eric Sprink characterized the charges as tied to an "isolated issue pertaining to one partner," and emphasized that the company took decisive action by recording the full potential impact in a single quarter. Management indicated the resolution timeline for the affected partner relationship could range from one to two quarters to as long as 12 to 18 months. On the positive side, the underlying BaaS platform continues to demonstrate momentum: BaaS program fee income rose 10.3% sequentially to $12.0 million, the partner pipeline includes entities in testing and onboarding phases, and off-balance-sheet credit card accounts with fee-earning potential surged 32.2% quarter-over-quarter to over 881,000. The company remains well capitalized, with a Common Equity Tier 1 ratio of 10.86% and over $1 billion in cash and cash equivalents. Still, risks remain: any indication that credit deterioration is spreading beyond the single flagged partner — or any additional partner departures — would likely trigger a second wave of selling.

Trending AI Robots

For traders looking to navigate volatile market environments with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to shifting market conditions. Tickeron hosts hundreds of AI trading bots covering thousands of tickers, but only those demonstrating the strongest performance under prevailing market dynamics are featured in this curated section. These bots vary by strategy, time horizon, performance metrics, and traded symbols, allowing users to explore a range of algorithmic approaches. Discover which AI trading strategies are currently outperforming by visiting the Trending AI Robots page today.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CCB

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Aroon Indicator for CCB shows an upward move is likely

CCB's Aroon Indicator triggered a bullish signal on July 27, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 243 similar instances where the Aroon Indicator showed a similar pattern. In of the 243 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CCB's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where CCB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CCB advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

CCB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCB as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CCB turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

CCB moved below its 50-day moving average on July 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CCB crossed bearishly below the 50-day moving average on July 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.673) is normal, around the industry mean (1.364). P/E Ratio (13.685) is within average values for comparable stocks, (24.357). CCB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.858). CCB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). CCB's P/S Ratio (1.697) is slightly lower than the industry average of (3.877).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CCB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are PNC Financial Services Group (NYSE:PNC), US Bancorp (NYSE:USB), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.5B. The market cap for tickers in the group ranges from 10.73K to 142.82B. CIHHF holds the highest valuation in this group at 142.82B. The lowest valued company is ACBCQ at 10.73K.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 12%. CCB experienced the highest price growth at 15%, while FGBI experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was -25%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 52
Price Growth Rating: 46
SMR Rating: 53
Profit Risk Rating: 55
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
CCB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a regional bank

Industry RegionalBanks

Profile
Details
Industry
Regional Banks
Address
5415 Evergreen Way
Phone
+1 425 257-9000
Employees
483
Web
https://www.coastalbank.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.